Healy Proclaims Her Long-Range Objective: Rapid Escalation In Number Of NIH Grants

Clearly established research goals, awards of shorter duration, and vigilance over costs will do the trick, says the agency,s director BETHESDA, Md.--National Institutes of Health director Bernadine Healy hopes to increase by almost 50 percent the total number of grants the agency awards over the next several years. To do it, she says, NIH must trim budget requests by principal investigators and tighten up on indirect costs paid to institutions, manipulate the length of its grants awarded to av

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

If successful, the plan over time could have a major impact on the way that scientists obtain their funding from the agency.

This year NIH will fund more than 21,000 research project grants, a number that has grown very slowly over the past several years. Healy, who became director in April, wants that number to top 30,000 annually by the end of the decade as part of a major campaign to increase federal support for her agency. At the same time, she and other NIH officials would like to see the success rate of applicants rise to at least one in three, from the current level of one in four. While those goals won't be achievable without additional money, Healy says, it will ensure that NIH sets ambitious objectives for itself and then works hard to meet them.

"What's happened to [the size of] our portfolio [of grants] over the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo